Åke Borg
Åke Borg
Department of Oncology, Clinical Sciences, Lund University, Sweden
Verified email at med.lu.se
Title
Cited by
Cited by
Year
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
52582013
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
The American Journal of Human Genetics 72 (5), 1117-1130, 2003
36882003
Zelada-Hedman M and the Breast Cancer Linkage Consortium (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ...
Am J Hum Genet 62, 676-689, 0
3473*
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ...
The American Journal of Human Genetics 62 (3), 676-689, 1998
34021998
Gene-expression profiles in hereditary breast cancer
I Hedenfalk, D Duggan, Y Chen, M Radmacher, M Bittner, R Simon, ...
New England Journal of Medicine 344 (8), 539-548, 2001
19692001
International network of cancer genome projects
International Cancer Genome Consortium
Nature 464 (7291), 993, 2010
15602010
Mutational processes molding the genomes of 21 breast cancers
S Nik-Zainal, LB Alexandrov, DC Wedge, P Van Loo, CD Greenman, ...
Cell 149 (5), 979-993, 2012
13002012
The life history of 21 breast cancers
S Nik-Zainal, P Van Loo, DC Wedge, LB Alexandrov, CD Greenman, ...
Cell 149 (5), 994-1007, 2012
10822012
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
9462016
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
LH Saal, K Holm, M Maurer, L Memeo, T Su, X Wang, SY Jennifer, ...
Cancer research 65 (7), 2554-2559, 2005
8992005
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns
S Gruvberger, M Ringnér, Y Chen, S Panavally, LH Saal, Å Borg, M Fernö, ...
Cancer research 61 (16), 5979-5984, 2001
8212001
Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype
L Holmquist-Mengelbier, E Fredlund, T Löfstedt, R Noguera, S Navarro, ...
Cancer cell 10 (5), 413-423, 2006
6412006
HER2/neu amplification predicts poor survival in node positive patients
A Borg, AK Tandon, H Sigurdsson, GM Clark, M Fernö, SAW Fuqua, ...
Cancer Res 50, 6701-6707, 1990
603*1990
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
G Honeth, PO Bendahl, M Ringnér, LH Saal, SK Gruvberger-Saal, ...
Breast Cancer Res 10 (3), R53, 2008
5602008
A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene
D Shattuck-Eidens, M McClure, J Simard, F Labrie, S Narod, F Couch, ...
JAMA: the journal of the American Medical Association 273 (7), 535-541, 1995
5561995
BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data
LH Saal, C Troein, J Vallon-Christersson, S Gruvberger, Å Borg, ...
Genome biology 3 (8), software0003. 1, 2002
5372002
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
LH Saal, P Johansson, K Holm, SK Gruvberger-Saal, QB She, M Maurer, ...
Proceedings of the National Academy of Sciences 104 (18), 7564-7569, 2007
5262007
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis
M Esteller, MF Fraga, M Guo, J Garcia-Foncillas, I Hedenfalk, AK Godwin, ...
Human molecular genetics 10 (26), 3001-3007, 2001
5192001
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
4852013
Amplification and deletion of topoisomerase IIα associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer
TAH Järvinen, M Tanner, V Rantanen, M Bärlund, Å Borg, S Grénman, ...
The American journal of pathology 156 (3), 839-847, 2000
4772000
The system can't perform the operation now. Try again later.
Articles 1–20